Citation Impact
5 from Science/Nature 53 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
2024 Standout
Works of Lin-Chi Chen being referenced
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia
2020
Phase 1 summary of plasma concentration–QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML
2018
Author Peers
| Author | Infectious Diseases | Oncology | Molecular Biology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Lin-Chi Chen | 178 | 215 | 230 | 225 | 18 | 607 | |
| Érika Ferreira Gomes | 5 | 14 | 413 | 17 | 754 | ||
| Hangqing Fan | 58 | 25 | 537 | ||||
| Hailyn V. Nielsen | 114 | 18 | 175 | 267 | 13 | 511 | |
| Barry S. Tuchfeld | 3 | 190 | 12 | 317 | |||
| A. Mazzucotelli | 1 | 10 | 24 | 4 | 47 | 774 |
All Works
Login with ORCID to disown or claim papers
Loading papers...